dexmedetomidine has been researched along with Angiogenesis, Pathologic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Y; Fang, Y; Huang, J; Qiao, F; Su, X; Wang, J; Yang, L | 1 |
1 other study(ies) available for dexmedetomidine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery.
Topics: Aged; Animals; Cell Line, Tumor; Cell Proliferation; Dexmedetomidine; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Mice, Inbred C57BL; Middle Aged; Monocytes; Myeloid-Derived Suppressor Cells; Neoplasm Metastasis; Neovascularization, Pathologic; Receptors, Adrenergic, alpha-2; Vascular Endothelial Growth Factor A | 2018 |